Abliva AB (NEVPF)
0.01
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Abliva Cash from Investing (TTM): -0.1218M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.1218M |
September 30, 2023 | -0.0574M |
June 30, 2023 | -0.0763M |
March 31, 2023 | -0.0979M |
December 31, 2022 | -0.0902M |
September 30, 2022 | -0.0858M |
June 30, 2022 | -0.1218M |
March 31, 2022 | -0.1218M |
December 31, 2021 | -0.1272M |
September 30, 2021 | -0.1358M |
June 30, 2021 | -0.1102M |
March 31, 2021 | -0.1032M |
December 31, 2020 | -0.1537M |
September 30, 2020 | -0.1434M |
June 30, 2020 | -0.2128M |
March 31, 2020 | -0.3115M |
December 31, 2019 | -0.2853M |
September 30, 2019 | -0.406M |
June 30, 2019 | -0.4011M |
March 31, 2019 | -0.3952M |
December 31, 2018 | -0.4461M |
September 30, 2018 | -0.3351M |
June 30, 2018 | -0.5055M |
March 31, 2018 | -0.4683M |
December 31, 2017 | -1.793M |
Date | Value |
---|---|
September 30, 2017 | -2.722M |
June 30, 2017 | -3.591M |
March 31, 2017 | -4.058M |
December 31, 2016 | -2.930M |
September 30, 2016 | -2.432M |
June 30, 2016 | -2.024M |
March 31, 2016 | -3.003M |
December 31, 2015 | -2.781M |
September 30, 2015 | -3.530M |
June 30, 2015 | -3.195M |
March 31, 2015 | -3.153M |
December 31, 2014 | -3.430M |
September 30, 2014 | -2.826M |
June 30, 2014 | -2.714M |
March 31, 2014 | -1.431M |
December 31, 2013 | -1.795M |
September 30, 2013 | -1.553M |
June 30, 2013 | -1.861M |
March 31, 2013 | -1.916M |
December 31, 2012 | -1.436M |
September 30, 2012 | -1.268M |
June 30, 2012 | -0.9961M |
March 31, 2012 | -0.9485M |
December 31, 2011 | -1.046M |
September 30, 2011 | -1.050M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.406M
Minimum
Sep 2019
-0.0574M
Maximum
Sep 2023
-0.1665M
Average
-0.1218M
Median
Mar 2022
Cash from Investing (TTM) Benchmarks
Karolinska Development AB | -3.475M |
Calliditas Therapeutics AB | -- |
Oncopeptides AB | -0.2606M |
Olink Holding AB | -22.43M |
BioInvent International AB | 24.48M |